Title of article
Conversion of an MMP-potent scaffold to an MMP-selective HER-2 sheddase inhibitor via scaffold hybridization and subtle permutations
Author/Authors
David M. Burns، نويسنده , , Chunhong He، نويسنده , , Yanlong Li، نويسنده , , Peggy Scherle، نويسنده , , Xiangdong Liu، نويسنده , , Cindy A. Marando، نويسنده , , Mayanne B. Covington، نويسنده , , Gengjie Yang، نويسنده , , Max Pan، نويسنده , , Sharon Turner، نويسنده , , Jordan S. Fridman، نويسنده , , Gregory Hollis، نويسنده , , Kris Vaddi، نويسنده , , Swamy Yeleswaram، نويسنده , , Robert Newton، نويسنده , , Steve Friedman، نويسنده , , Brian Metcalf، نويسنده , , Wenqing Yao، نويسنده ,
Issue Information
روزنامه با شماره پیاپی سال 2008
Pages
5
From page
560
To page
564
Abstract
A series of β-sulfonamide piperidine hydroxamates were prepared and shown to be potent inhibitors of the human epidermal growth factor receptor-2 (HER-2) sheddase with excellent selectivity against MMP-1, −2, −3, and −9. This was achieved by exploiting subtle differences within the otherwise highly conserved binding pocket of the active sites within the metalloprotease family. In addition, it was discovered that the introduction of polarity to the P1 and groups reduced the projected human clearance.
Keywords
HER-2 sheddase , ADAM-10 , Beta-sulfonamide piperidine hydroxamates , metalloprotease , MMP , P1? substituent , Projected clearnace , Scaffold hybridization
Journal title
Bioorganic & Medicinal Chemistry Letters
Serial Year
2008
Journal title
Bioorganic & Medicinal Chemistry Letters
Record number
799015
Link To Document